Share：
Share this content in WeChat
X
[Chinese][PDF]809107
• Clinical Article •
Applying magnetic resonance rapid liver fat quantification to monitor liver fat changes in patients with obese type 2 diabetes mellitus
WEI Wei  BAI Yan  MA Lun  SHI Shao-jie  WANG Yan  WANG Mei-yun 

DOI:10.12015/issn.1674-8034.2018.12.006.


[Abstract] Objective: To evaluate the feasibility and accuracy of magnetic resonance imaging six-echo Dixon rapid liver fat quantitative analysis for the changes of liver fat content in the patients with obese type 2 diabetes (T2DM), and reveal the relationship between the changes in liver fat fraction and body weight, body mass index (BMI) or glycosylated hemoglobin (HbA1c) after the three-months treatment.Materials and Methods: This study included 21 patients with clinical diagnosed obese T2MD, They lost the weight and controlled the blood glucose according to the Chinese Type 2 Diabetes Prevention Guide (2013 edition) recommended intensive lifestyle intervention with acarbose of a three-month treatment period. All patients underwent liver scan by using T2*-corrected six-echo Dixon sequence in Siemens 1.5 T MRI scanner before and after treatment, respectively. After the image acquisition was completed, the average fat content of the liver was quantitatively analyzed by the rapid fat quantification and manual draw region of interest (ROI). Finally, the Bland-Altman plots and Pearson correlation analysis were performed on the quantitative results of the above two methods. Furthermore, we analysed the correlation between the change in liver fat content and the change in the body weight, BMI or HbA1c after the three-months treatment.Results: The six-echo Dixon rapid liver fat quantification results were highly correlated with the manual draw ROI measurements for patients in the two examinations, respectively (r=0.993 and 0.985, respectively, both P<0.01). The Bland-Altman analysis showed that the average difference between the rapid liver fat quantification and manual ROI was 0.99 (95% confidence interval,-0.56 to 2.54) and 1.23 (95% confidence interval,-0.81 to 3.28) in the two examinations (20/21 differences were within range of 95% confidence interval), respectively. The significant correlations were also found between the change of liver fat fraction and the change of body weight, BMI or HbA1c after treatment (r=0.508, 0.514 and 0.467, respectively; P=0.019, 0.017 and 0.033, respectively).Conclusions: The MRI six-echo Dixon rapid liver fat quantification can simply, feasibility and accurately assess the change of liver fat content in the patients with obese T2DM. Moreover, it is helpful for investigating the association between the change of liver fat content and the change of body weight, BMI or HbA1c.
[Keywords] Magnetic resonance imaging；Diabetes mellitus, type 2；Obesity；Liver fat quantification

WEI Wei Medical College of Henan University, Kaifeng 475000, China

BAI Yan Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou 450003, China; Henan Key Laboratory for Medical Imaging of Neurological Disease, Zhengzhou 450003, China

MA Lun Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou 450003, China

SHI Shao-jie Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou 450003, China

WANG Yan Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou 450003, China

WANG Mei-yun* Medical College of Henan University, Kaifeng 475000, China; Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou 450003, China; Henan Key Laboratory for Medical Imaging of Neurological Disease, Zhengzhou 450003, China

*Correspondence to: Wang MY, E-mail: marian9999@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation No.81720108021, 81641168 National Key Research and Development Program No.2017YFE0103600 Henan Provincial Scientific and Technological Open and Cooperating Project No.152106000014 Henan Provincial Medical Scientific and Technological Research Project No.201501011
Received  2018-08-13
DOI: 10.12015/issn.1674-8034.2018.12.006
DOI:10.12015/issn.1674-8034.2018.12.006.

[1]
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet, 2017, 389(10085): 2239-2251.
[2]
Fujioka K. Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes Obes Metab, 2010, 12(3): 186-194.
[3]
柴军，刘朋，洪旭，等．化学位移MRI对初诊2型糖尿病患者及健康人胰腺脂肪含量的比较研究．磁共振成像, 2015, 6(3): 208-212.
[4]
Karampinos DC, Baum T, Nardo L, et al. Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift-based water/fat separation. J Magn Reson Imaging, 2012, 35(4): 899-907.
[5]
Sun W, Zeng C, Liao L, et al. Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity. Curr Med Res Opin, 2016, 32(8): 1389-1396.
[6]
Patel NS, Doycheva I, Peterson MR, et al. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol, 2015, 13(3): 561-568.
[7]
Leitão HS, Paulino C, Rodrigues D, et al. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients. Acad Radiol, 2013, 20(8): 957-961.
[8]
Dong Z, Luo Y, Cai H, et al. Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes. Medicine (Baltimore), 2016, 95(23): e3858.
[9]
Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology, 2011, 258(3): 749-759.
[10]
Vu KN, Gilbert G, Chalut M, et al. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes. J Magn Reson Imaging, 2016, 43(5): 1090-1099.
[11]
Dong Z, Luo Y, Zhang Z, et al. MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects. PLoS One, 2014, 9(10): e111283.
[12]
Emdin CA, Khera AV, Natarajan P, et al. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA, 2017, 317(6): 626-634.
[13]
窦京涛．肥胖与2型糖尿病关系新认识．药品评价, 2018, 15(3): 5.
[14]
Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science, 2011, 332(6037): 1519-1523.
[15]
Middleton MS, Haufe W, Hooker J, et al. Quantifying abdominal adipose tissue and thigh muscle volume and hepatic proton density fat fraction: repeatability and accuracy of an MR imaging-based, semiautomated analysis method. Radiology, 2017, 283(2): 438-449.
[16]
郁伟斌，李跃华．磁共振技术在非酒精性脂肪肝病中准确定量脂肪含量的应用．磁共振成像, 2016, 7(10): 797-800.
[17]
周围，陈晓巧，周园园，等．磁共振Dixon技术全肝脂肪定量与肝穿刺活检结果比较．医学影像学杂志, 2018, 28(5): 775-780.
[18]
Bonekamp S, Tang A, Mashhood A, et al. Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging, 2014, 39(6): 1525-1532.
[23]
吕娟．肥胖与糖化血红蛋白的相关性研究．基层医学论坛, 2013, 17(22): 2941-2942.

PREV The value of histogram analysis of apparent diffusion coefficient in distinguishing the molecular subtypes of mass-like breast cancer
NEXT Imaging features of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in adults
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn